Back
United Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
54
UTHR
United Therapeutics
Last Price:
373.01
Seasonality Move:
10.82%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- The current trend is relatively stagnant and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
United Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 371.83 | Buy |
| 20-day SMA: | 377.86 | Sell |
| 50-day SMA: | 364.37 | Buy |
| 200-day SMA: | 301.7 | Buy |
| 8-day EMA: | 372.22 | Buy |
| 20-day EMA: | 374.08 | Sell |
| 50-day EMA: | 365.04 | Buy |
| 200-day EMA: | 315.95 | Buy |
United Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.44 | Buy |
| Relative Strength Index (14 RSI): | 50.17 | Buy |
| Chaikin Money Flow: | 160316 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (355.44 - 392.52) | Sell |
| Bollinger Bands (100): | (328.78 - 370.78) | Buy |
United Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 372.89 while UTHR 8-day simple moving average is 371.83, which is a Buy signal.
- The stock price of UTHR is 372.89 while United Therapeutics 20-day SMA is 377.86, which makes it a Sell.
- United Therapeutics 50-day simple moving average is 364.37 while UTHR share price is 372.89, making it a Buy technically.
- UTHR stock price is 372.89 and United Therapeutics 200-day simple moving average is 301.70, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
54
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a Buy
The current United Therapeutics [UTHR] share price is $372.89. The Score for UTHR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Stock Info
Market Cap:
16.65B
Price in USD:
372.89
Share Volume:
254.18K
United Therapeutics 52-Week Range
52-Week High:
417.82
52-Week Low:
208.62
Buy
54
United Therapeutics (UTHR)
is a Buy
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?
The United Therapeutics stock price is 372.89 USD today. -
Will UTHR stock go up or go down?
United Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is United Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is not overvalued.
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 372.89 while UTHR 8-day exponential moving average is 372.22, which is a Buy signal.
- The stock price of UTHR is 372.89 while United Therapeutics 20-day EMA is 374.08, which makes it a Sell.
- United Therapeutics 50-day exponential moving average is 365.04 while UTHR share price is 372.89, making it a Buy technically.
- UTHR stock price is 372.89 and United Therapeutics 200-day simple moving average is 315.95, creating a Buy signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.71 per share, and an increase next year of $2.60 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
- UTHR Moving Average Covergence Divergence (MACD) indicator is 1.44, suggesting United Therapeutics is a Buy
- United Therapeutics Relative Strength Index (RSI) is 50.17, which suggest United Therapeutics is overbought
- The Bollinger Bands (25) for United Therapeutics is (355.44 - 392.52), which suggest United Therapeutics is a Buy
- The Bollinger Bands (100) for United Therapeutics is (328.78 - 370.78), which suggest United Therapeutics is a Buy
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.